Duan Jia-Yu, Cui Jian, Tang Wen-Jiao, Zou Zhong-Qing, Zhang Li
Institute of Hematology,Department of Hematology,West China Hospital,Sichuan University,Chengdu 610041,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Aug;44(4):673-677. doi: 10.3881/j.issn.1000-503X.13467.
Multiple myeloma is a hematologic tumor characterized by clonal proliferation of plasma cells.The development of novel agents and immunotherapy have substantially improved the prognosis of multiple myeloma,with an expectable median survival beyond ten years.Therefore,there is an urgent need to improve the management of this disease.Health management is effective in controlling chronic diseases and full-cycle management should be implemented from the early to the end stage of the disease.Implanting the full-cycle concept into the health management of multiple myeloma will guide and standardize the advances in this field.This review focuses on the full-cycle concept of multiple myeloma and the corresponding application of health management at each stage of the cycle.
多发性骨髓瘤是一种以浆细胞克隆性增殖为特征的血液肿瘤。新型药物和免疫疗法的发展显著改善了多发性骨髓瘤的预后，预计中位生存期超过十年。因此，迫切需要改进这种疾病的管理。健康管理在控制慢性病方面有效，应从疾病的早期到终末期实施全周期管理。将全周期理念植入多发性骨髓瘤的健康管理中将指导并规范该领域的进展。本综述重点关注多发性骨髓瘤的全周期理念以及在该周期各阶段健康管理的相应应用。
